Pacific Biosciences of California, Inc. (PACB) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 310.83M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 310.83M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 310.83M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 310.83M | (m) | (m) |
| 2026-03-31 | 310.60M | (m) | (m) |
| 2025-12-31 | 302.00M | (m) | (m) |
| 2025-09-30 | 301.91M | (m) | (m) |
| 2025-06-30 | 300.37M | (m) | (m) |
| 2025-03-31 | 300.08M | (m) | (m) |
| 2024-12-31 | 297.85M | (m) | (m) |
| 2024-09-30 | 273.86M | (m) | (m) |
| 2024-06-30 | 272.53M | (m) | (m) |
| 2024-03-31 | 272.36M | (m) | (m) |
| 2023-12-31 | 267.95M | (m) | (m) |
| 2023-09-30 | 267.44M | (m) | (m) |
| 2023-06-30 | 250.56M | (m) | (m) |
| 2023-03-31 | 249.89M | (m) | (m) |
| 2022-12-31 | 247.08M | (m) | (m) |
| 2022-09-30 | 226.11M | (m) | (m) |
| 2022-06-30 | 224.84M | (m) | (m) |
| 2022-03-31 | 224.38M | (m) | (m) |
| 2021-12-31 | 221.18M | (m) | (m) |
| 2021-09-30 | 220.60M | (m) | (m) |
| 2021-06-30 | 199.00M | (m) | (m) |
| 2021-03-31 | 198.37M | (m) | (m) |
| 2020-12-31 | 193.10M | (m) | (m) |
| 2020-09-30 | 180.21M | (m) | (m) |
| 2020-06-30 | 154.41M | (m) | (m) |
| 2020-03-31 | 154.07M | (m) | (m) |
| 2019-12-31 | 153.14M | (m) | (m) |
| 2019-09-30 | 153.03M | (m) | (m) |
| 2019-06-30 | 152.96M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |